Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2026-01-02 @ 6:41 AM
Study NCT ID:
NCT04369469
Status:
TERMINATED
Last Update Posted:
2022-05-24
First Post:
2020-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-28
First Submit QC Date:
None
Study First Post Date:
2020-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-02-15
Results First Submit QC Date:
None
Results First Post Date:
2022-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-04
Last Update Post Date:
2022-05-24
Last Update Post Date Type:
ACTUAL